Syringe

- GALDERMA HOLDING SA
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a top front perspective view of a syringe according to the claimed design;

FIG. 2 is a bottom front perspective view thereof;

FIG. 3 is a left rear perspective view thereof;

FIG. 4 is right rear perspective view thereof;

FIG. 5 is a front view thereof

FIG. 6 is a rear view thereof;

FIG. 7 is a top perspective view of a portion of the syringe of FIG. 1;

FIG. 8 is a bottom perspective view thereof;

FIG. 9 is a front view thereof;

FIG. 10 is a left side view thereof;

FIG. 11 is a top view thereof; and,

FIG. 12 is a bottom view thereof.

The broken lines in the drawings illustrate portions of the syringe and form no part of the claimed design. The break lines indicate that the appearance of any portion of the syringe between the break lines forms no part of the claimed design.

Claims

We claim the ornamental design for a syringe, as shown and described.

Referenced Cited
U.S. Patent Documents
D397790 September 1, 1998 Naganuma
D425198 May 16, 2000 Porta
D620591 July 27, 2010 Young
D641078 July 5, 2011 Morgan
D668760 October 9, 2012 Kawamura
D675317 January 29, 2013 Baxter et al.
D710005 July 29, 2014 Kawamura
D777325 January 24, 2017 Aneas
D790691 June 27, 2017 Davis et al.
D793552 August 1, 2017 Schiller et al.
D794185 August 8, 2017 Dolk et al.
D796670 September 5, 2017 Dolk
D797282 September 12, 2017 Dolk et al.
D798444 September 26, 2017 Darras et al.
D799034 October 3, 2017 Nguyen
D800900 October 24, 2017 Darras et al.
D812223 March 6, 2018 Evans et al.
D814026 March 27, 2018 Darras et al.
D815279 April 10, 2018 Darras et al.
D842463 March 5, 2019 Grunhut
D845476 April 9, 2019 Evans et al.
D865949 November 5, 2019 Mandaroux
D866753 November 12, 2019 Mandaroux
D867582 November 19, 2019 Mandaroux
10857306 December 8, 2020 Holmqvist
D914208 March 23, 2021 Shabudin et al.
D954942 June 14, 2022 Lee
20090137966 May 28, 2009 Rueckert et al.
20120220948 August 30, 2012 Barbour
20180243513 August 30, 2018 Rolfs et al.
Foreign Patent Documents
008584866-0001 June 2021 EM
1802332-0002 July 2019 HK
D1067331 April 2000 JP
300926536 October 2017 KR
300926537 October 2017 KR
300932430.0000 November 2017 KR
101900427 September 2018 KR
301158293 April 2022 KR
WO-2017/176476 October 2017 WO
WO-2021/220228 November 2021 WO
Other references
  • Restylane Defyne (1X1ML) QMED Galderma, Restylane—QMED—Galderma, France HEalth, [Post date unknown], site seen [Jul. 20, 2022], Seen at URL: https://www.france-health.com/en/home/4894-restylane-defyne-1x1ml-qmed-galderma.html (Year: 2022).
  • Author: Thierry, Bi-Soft, Reinventing the syringe, Anti-age Magazine, [Post date: Unknown], [Site seen Jul. 20, 2022], Seen at URL: https://en.anti-age-magazine.com/bi-soft-re-inventing-syringe/ (Year: 2022).
  • International Search Report and Written Opinion for related International Patent Application No. PCT/IB2021/053601 dated May 25, 2021.
  • U.S. Appl. No. 29/763,036, filed Dec. 21, 2020, Galderma S.A.
  • Excerpt from “BD add-on finger flange,” BD, bd.com, 2022, 1 page, https://drugdeliverysystems.bd.com/products/safety-and-shielding-systems/add-on-finger-flange (accessed Jul. 14, 2022).
  • “Restylane Defyne (1×1 ML) QMED Galderma,” Restylane—QMED—Galderma, France-Health, https://www.france-health.com/en/home/4894-restylane-defyne-1x1ml-qmed-galderma.html, (accessed Jul. 14, 2022), 1 page.
  • Notice of Allowance on U.S. Appl. No. 29/763,036 dated Aug. 8, 2022 (8 pages).
Patent History
Patent number: D973873
Type: Grant
Filed: Jun 21, 2021
Date of Patent: Dec 27, 2022
Assignee: GALDERMA HOLDING SA (Zug)
Inventors: Oliver Tyrsing (Uppsala), Oscar Ullsten (Uppsala)
Primary Examiner: Natasha Vujcic
Assistant Examiner: Gilbert B Ford
Application Number: 29/795,863
Classifications